Physical and mental impact of psoriasis severity as measured by the compact short form-12 health survey (SF-12) quality of life tool

Journal of Investigative Dermatology

Volumn 132, Issue 4, 2012, Pages 1111-1116

  Grozdev, Ivan ^a   Kast, Douglas ^a   Cao, Lauren ^a   Carlson, Diana ^a   Pujari, Prasad ^a   Schmotzer, Brian ^a   Babineau, Denise ^a   Kern, Elizabeth ^a   McCormick, Thomas ^a   Cooper, Kevin D ^a   Korman, Neil J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BODY MASS; CLINICAL ASSESSMENT TOOL; COMORBIDITY; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL; PSORIASIS; PSORIASIS AREA SEVERITY INDEX; PSORIATIC ARTHRITIS; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SHORT FORM 12;

EID: 84858289488     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.427     Document Type: Article

References (26)

1. Bhosle MJ, Kulkarni A, Feldman SR et al. (2006) Quality of life in patients with psoriasis. Health Qual Life Outcomes 4:35
2. Bronsard V, Paul C, Prey S et al. (2010) What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol 24(Suppl 2):17-22
3. Charlson ME, Pompei P, Ales KL et al. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chron Dis 40:373-83
4. De Arruda LH, De Moares AP (2001) The impact of psoriasis on quality of life. Br J Dermatol 144:33-5
5. Feldman SR, Fleischer AB Jr, Reboussin DM et al. (1997) The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol 37:564-9
6. Feldman SR, Koo JY, Menter A et al. (2005) Decision points for the initiation of systemic treatment for psoriasis. J Am Acad Dermatol 53:101-7
7. Finlay AY, Coles EC (1995) The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 132:236-44
8. Finlay AY, Khan GK (1994) Dermatology life quality ondex (DLQI)-A simple practical measure for routine clinical use. Clin Exp Dermatol 19:210-5
9. Fleischer AB Jr, Feldman SR, Rapp SR et al. (1996) Disease severity measures in a population of psoriasis patients: The symptoms of psoriasis correlate with self-Administered psoriasis area severity index scores. J Invest Dermatol 107:26-9
10. Fortune DG, Richards HL, Griffiths CE (2005) Psychologic factors in psoriasis: Consequences, mechanisms, and interventions. Dermatol Clin 23:681-94
11. Gelfand JM, Feldman SR, Stern RS et al. (2004) Determinants of quality of life in patients with psoriasis: A study from the US population. J Am Acad Dermatol 51:704-8
12. Jankovic S, Raznatovic M, Marinkovic J et al. (2011) Health-related quality of life in patient with psoriasis. J Cutan Med Surg 15:29-35
13. Katz JN, Cjang LC, Sangha O et al. (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34: 73-84
14. Khanna D, Frech T, Khanna PP et al. (2010) Valuation of scleroderma and psoriatic arthritis health states by the generic public. Health Qual Life Outcomes 8:112
15. Kirby B, Richards HL, Woo P et al. (2001) Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 45:72-5
16. Krueger G, Koo J, Lebwohl M et al. (2001) The impact of psoriasis on quality of life: Results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 137:280-4
17. Nichol MB, Margolies JE, Lippa E et al. (1996) The application of multiple quality-of-life instruments in individuals with mild-to-moderate psoriasis. Pharmacoeconomics 10:644-53
18. Patrick DL, Deyo RA (1989) Generic and disease-specific measures in assessing health status and quality of life. Med Care 27(3 Suppl):S217-32
19. Rapp SR, Feldman SR, Exum ML et al. (1999) Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 41:401-7
20. Shikiar R, Willian MR, Okun MM et al. (2006) The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: Results of a phase II study. Health Qual Life Measures 4:71
21. Stern RS, Nijsten T, Feldman SR et al. (2004) Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 9:136-9
22. Tadros A, Vergou T, Stratigos A et al. (2011) Psoriasis: Is it the tip of the iceberg for the quality of life of patients and their families? Eur Acad Dermatol Venereol 25:1282-7
23. Unaeze J, Nijsten T, Murphy A et al. (2006) Impact of psoriasis on healthrelated quality of life decreases over time: An 11-year prospective study. J Invest Dermatol 126:1480-9
24. Ware JE Jr, Kosinski M, Turner-Bowker DM et al. (eds). (2002) User's Manual for the SF-12v2 Health Survey with a Supplement Documenting SF-12 Health Survey. Lincoln, RI: QualityMetric Incorporated
25. Weiss SC, Kimball AB, Liewehr DJ et al. (2002) Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol 47:512-8
26. Zachariae R, Zachariae H, Blomqvist K et al. (2002) Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol 146:1006-15